Healthcare Global Enterprises Ltd
Healthcare | Small Cap
Health Score : 4.53Healthcare Global Enterprises Ltd demonstrates a mixed financial performance. The company shows strong solvency due to high equity, but struggles with liquidity as indicated by low current, quick, and cash ratios. Efficiency is also a concern, with low turnover ratios suggesting challenges in asset utilization. Revenue and net income growth are absent, but the company has shown good operating profit and asset growth. Coverage ratios are weak, reflecting potential difficulties in meeting financial obligations. While profitability metrics like ROCE and ROA are strong, others such as gross profit margin and net margin are low, creating an imbalanced view. Overall, the company needs to focus on improving its liquidity and efficiency while maintaining its solvency and focusing on profitability and revenue growth.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.00
- Financial Ratio4.00
- Profitability Ratio4.80
- Efficiency Ratio4.67
- Coverage Ratio3.20
- Solvency Ratio10.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBearish
- 2 HoursBearish
- 4 HoursBearish
- 1 DayNeutral
- 1 WeekBullish
- 1 MonthBullish
Health Score : 4.53Healthcare Global Enterprises Ltd demonstrates a mixed financial performance. The company shows strong solvency due to high equity, but struggles with liquidity as indicated by low current, quick, and cash ratios. Efficiency is also a concern, with low turnover ratios suggesting challenges in asset utilization. Revenue and net income growth are absent, but the company has shown good operating profit and asset growth. Coverage ratios are weak, reflecting potential difficulties in meeting financial obligations. While profitability metrics like ROCE and ROA are strong, others such as gross profit margin and net margin are low, creating an imbalanced view. Overall, the company needs to focus on improving its liquidity and efficiency while maintaining its solvency and focusing on profitability and revenue growth.
Overall Valuation Score
P/E RATIO (TTM)
623.42
Industry Median
47.76
Small Cap Median
45.36
P/E RATIO
664.08
P/B RATIO
6.85
Industry Median
4.54
Small Cap Median
3.95
P/S RATIO
3.61
Industry Median
3.59
Small Cap Median
2.22
Others
PEG RATIO
0.00
EV/EBITDA RATIO
22.50
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹610.95 as on Jun 19, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Growth Score : 4.00The company's growth ratios show a mixed performance. While operating profit and asset growth rates are strong, revenue and net income growth are absent. The earnings per share growth is minimal suggesting challenges in translating profit into shareholder value. Overall, the company needs to focus on strategies to boost revenue and net income to achieve balanced growth.
Revenue Growth RatePoor
Operating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 38.26 | 21.22 | 12.83 | 16.25 | 14.74 |
| Operating Profit Growth Rate | 91.8 | 26.92 | 10.1 | 17.43 | 21.35 |
| Earnings Per Share (EPS) Growth | -125.03 | -45.48 | 64.32 | -7.95 | -69.44 |
| Asset Growth Rate | 9.21 | 4.19 | 16.88 | 31.06 | 10.82 |
| Net Income Growth Rate | -117.65 | -53.85 | 127.78 | 19.51 | -53.06 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 4.00The company's financial ratios present a mixed picture. While capital expenditures are well-managed, adjusted earnings per share, book value per share and dividend per share are minimal. Cash earnings per share is low, indicating challenges in translating profit into shareholder value. Overall, the company needs to focus on strategies to boost earnings to achieve balanced financial growth.
Adjusted Earnings Per Share (Adjusted EPS)PoorCash Earnings Per Share (Cash EPS)WeakBook Value Per SharePoorDividend Per Share (DPS)PoorCapital Expenditures (CapEx)Excellent| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | -1.51 | 0.49 | 2.38 | 3.88 | 3.81 |
| Cash Earnings Per Share (Cash EPS) | 14.17 | 13.02 | 15.47 | 18.71 | 17.92 |
| Book Value Per Share | 62.59 | 61.87 | 59.35 | 66.33 | 89.4 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 70 | 125 | 184 | 207 | 288 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 4.80The company's profitability ratios present a mixed performance. While ROCE and ROA are strong, gross profit margin, return on equity, operating margin, and net margin are low. This indicates potential challenges in converting revenue into profit. Improving cost management and operational efficiency is essential to enhance overall profitability.
Gross Profit MarginPoorReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)PoorReturn on Assets (ROA)ExcellentOperating MarginPoorNet MarginPoor| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 5.45 | 7.92 | 8.02 | 7.8 | 8.72 |
| Return on Capital Employed (ROCE) | 5 | 8 | 9 | 9 | 8 |
| Return on Equity (ROE) | 4.48 | 2.09 | 4.97 | 5.31 | 1.73 |
| Return on Assets (ROA) | 10.55 | 12.85 | 12.11 | 10.85 | 11.88 |
| Operating Margin | 16.77 | 17.56 | 17.14 | 17.31 | 18.31 |
| Net Margin | 2.8 | 1.06 | 2.15 | 2.21 | 0.9 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 4.67The company's efficiency ratios present a mixed picture. While days sales in inventory and receivable days are well-managed, the fixed asset, inventory, receivables, and capital turnover ratios are low. This indicates potential challenges in utilizing assets effectively to generate revenue. Overall, there may be inefficiencies in asset management that need to be addressed.
Fixed Asset Turnover RatioPoorInventory Turnover RatioPoorReceivables Turnover RatioPoorDays Sales in Inventory RatioExcellentReceivable DaysExcellentCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 0.9 | 1.09 | 1.09 | 0.91 | 1.03 |
| Inventory Turnover Ratio | 51.73 | 45.79 | 43.33 | 42.62 | 41.13 |
| Receivables Turnover Ratio | 6.91 | 6.5 | 6.39 | 6.38 | 6.19 |
| Days Sales in Inventory Ratio | 7.06 | 7.97 | 8.42 | 8.56 | 8.87 |
| Receivable Days | 52.82 | 56.15 | 57.12 | 57.21 | 58.97 |
| Capital Turnover Ratio | 0.8 | 0.98 | 1 | 0.94 | 0.92 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 3.20The company's coverage ratios are weak, primarily due to a low interest coverage ratio and minimal equity dividend coverage. This suggests potential difficulties in meeting its debt obligations and providing returns to equity holders. Improving profitability and cash flow is essential to strengthen coverage ratios.
Interest Coverage RatioWeakEquity Dividend Coverage RatioPoor| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 1.9 | 1.43 | 1.62 | 1.37 | 1.15 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 10.00The company exhibits strong solvency, primarily driven by a high equity ratio and minimal debt. The company's financial structure is heavily funded by equity rather than debt, reducing financial risk. Low debt ratios also provides the company with opportunities for growth through future borrowing. This robust solvency position provides a stable foundation for long-term sustainability.
Debt RatioExcellentDebt to Equity RatioExcellentEquity RatioExcellentDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.5 | 0.5 | 0.57 | 0.61 | 0.52 |
| Debt to Equity Ratio | 1 | 1 | 1.33 | 1.56 | 1.08 |
| Equity Ratio | 0.5 | 0.5 | 0.43 | 0.39 | 0.48 |
| Debt To Asset Ratio | 0.39 | 0.37 | 0.4 | 0.41 | 0.36 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 2.00The company's liquidity position is notably weak. The current, quick, and cash ratios are all at minimal levels, indicating a struggle to meet short-term obligations with available liquid assets. This could pose risks in managing day-to-day operations and unforeseen expenses. The operating cash flow ratio also shows that the company is not generating enough cash from its operations to cover its short-term liabilities. This constrained liquidity could limit the company's flexibility and growth potential.
Current RatioPoorQuick RatioPoorCash RatioPoorOperating Cash Flow RatioPoor| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.34 | 1.24 | 1.08 | 0.9 | 1.22 |
| Quick Ratio | 1.28 | 1.18 | 1.02 | 0.86 | 1.17 |
| Cash Ratio | 0.41 | 0.34 | 0.38 | 0.3 | 0.46 |
| Operating Cash Flow Ratio | 0.46 | 0.43 | 0.36 | 0.27 | 0.3 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Indraprastha Medical Corporation Ltd | 8.72 | 19.12 | Neutral | 267.00 | 20.03 | 184.00 |
| 2 | Jupiter Life Line Hospitals Ltd | 7.94 | 45.36 | Overvalued | 343.00 | 29.19 | 194.00 |
| 3 | Artemis Medicare Services Ltd | 7.77 | 39.49 | Overvalued | 188.00 | 6.53 | 104.00 |
| 4 | Rainbow Childrens Medicare Ltd | 5.74 | 53.68 | Neutral | 544.00 | 24.62 | 282.00 |
| 5 | Yatharth Hospital & Trauma Care Services Ltd | 4.89 | 46.14 | Neutral | 292.00 | 9.90 | 170.00 |
| 6 | Healthcare Global Enterprises Ltd | 4.53 | 664.08 | Neutral | 466.00 | 0.98 | 23.00 |
Balanced ManagementThe management effectiveness of Healthcare Global Enterprises Ltd. presents a mixed outlook. Strong sales growth and substantial promoter holding indicate positive strategic initiatives and aligned interests. However, fluctuating profit growth and increasing debt raise concerns about financial stability. While ROCE is improving, it remains at a moderate level. These factors suggest a need for cautious monitoring of financial strategies.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (TTM) | 17% | Demonstrates strong revenue expansion. |
| Promoter Holding (Mar 2025) | 71.22% | Indicates strong management and shareholder alignment. | |
| CONS | Compounded Profit Growth (TTM) | 10% | Shows recent deceleration in profit growth. |
| Borrowings (Mar 2025) | ₹1,837 Cr | Indicates increasing financial leverage. |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsAverageFinancial Health & PrudenceWeak
Shareholding & Ownership StructureGoodFinancial Performance & Growth
Healthcare Global Enterprises showcases robust revenue expansion, as seen in its compounded sales growth. The quarterly sales also display a consistent rise, from ₹364.63 Cr in Mar 2022 to ₹585.16 Cr in Mar 2025. However, profit growth has shown volatility. Recent quarterly results indicate fluctuations in net profit, which impacts overall profitability. The OPM% exhibits variability, ranging from 17.32% in Mar 2022 to 18.05% in Mar 2025, indicating operational efficiency variations. This combination of strong sales growth but inconsistent profit trends signals the need for strategic adjustments to stabilize and enhance profitability.
| Metric | 2017–2019 | 2020–2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Sales Growth (%) | 20.7% | 20.9% | 17.5% | 12.8% | 16.5% |
| Profit Growth (%) | -19.7% | -53.0% | -53.8% | 127.8% | 19.5% |
Capital Efficiency & Returns
The capital efficiency and returns for Healthcare Global Enterprises present a mixed scenario. The ROCE% has improved, with the latest value at 9% in Mar 2025. This indicates an improvement in the productivity of capital employed. However, the ROE% remains low at 5% in the last year, suggesting that shareholder funds are not generating high returns. The negative Cash Conversion Cycle indicates efficient working capital management.
| Metric | 2014–2016 | 2017–2019 | 2020–2022 | 2023 | 2024 | 2025 | |---------------------------|-----------|-----------|------|------|------| | ROCE (%) | 4.7 | 5.3 | 1.7 | 8.0 | 9.0 | 9.0 |
Financial Health & Prudence
The financial health of Healthcare Global Enterprises is concerning due to increasing debt levels. Borrowings have risen significantly, from ₹292 Cr in Mar 2014 to ₹1,837 Cr in Mar 2025. The Debt/Equity ratio reflects this increasing leverage. Interest Coverage Ratio has fluctuated due to variations in operating profit and rising interest expenses. The company has not been paying dividends.
| Metric | 2014–2016 | 2017–2019 | 2020–2022 | 2023 | 2024 | 2025 | |---------------------------|-----------|-----------|------|------|------| | Borrowings (₹Cr) | 321.7 | 514.0 | 1079.7 | 901 | 1274 | 1837 | | Interest Coverage Ratio | -0.7 | 0.2 | -0.6 | -0.6 | -0.4 | -0.6 |
Shareholding & Ownership Structure
The shareholding pattern of Healthcare Global Enterprises indicates strong promoter confidence, with a consistently high promoter holding around 71% from June 2022 to March 2025. There has been a decreasing trend in FII holdings, dropping from 7.22% in June 2022 to 2.44% in March 2025. Conversely, DII holdings have increased from 4.55% in June 2022 to 12.48% in March 2025. Public shareholding has remained relatively stable, fluctuating between 16.81% and 12.84%.
| Metric | Mar 2016 | Mar 2019 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Promoter Holding (%) | 24.61 | 24.11 | 71.43 | 71.37 | 71.28 | 71.22 |
| FII Holding (%) | 0.00 | 33.08 | 6.99 | 6.37 | 6.74 | 2.44 |
| DII Holding (%) | 56.70 | 25.10 | 5.86 | 5.53 | 8.52 | 12.48 |
Balanced RiskThe risk assessment for Healthcare Global Enterprises suggests a moderate level of concern. Strengths in sales growth and promoter holding are offset by increasing debt and fluctuating profit growth. The decreasing FII stake and moderate ROCE add to the risk profile. Financial management and strategic initiatives are necessary to mitigate these risks. Overall, the company needs to address its financial vulnerabilities.
Off-balance sheet exposure quantificationAverageContingent liability evaluationAverageAccounting quality red flagsGoodSegment performance volatilityAverageForeign exchange or interest rate exposureAverageRegulatory compliance cost trendsAverageOff-balance sheet exposure quantification
There is no specific data available on off-balance sheet exposures. Therefore, it is challenging to quantify the potential risks associated with such exposures.
Contingent liability evaluation
There is no specific data available on contingent liabilities. Therefore, a comprehensive evaluation of potential contingent liabilities is not possible with the given data.
Accounting quality red flags
There is no specific data available indicating accounting quality red flags.
Segment performance volatility
There is no specific data available on segment performance volatility. Therefore, it is not possible to assess the stability and consistency of performance across different segments of the company.
Foreign exchange or interest rate exposure
There is no specific data available on foreign exchange or interest rate exposure. Therefore, the potential risks from currency fluctuations or interest rate changes cannot be determined.
Regulatory compliance cost trends
There is no specific data available on regulatory compliance cost trends. Therefore, it is not possible to evaluate the increasing or decreasing trends of these costs and their impact on the company's financials.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10614.43Bearish
- SMA 20620.17Bearish
- SMA 50626.42Bearish
- EMA 10614.90Bearish
- EMA 20618.51Bearish
- EMA 50624.86Bearish
- DEMA 10611.25Bearish
- DEMA 20612.66Bearish
- DEMA 50617.46Bearish
- TEMA 10611.08Bearish
- TEMA 20610.84Bearish
- TEMA 50614.03Bearish
- MACD-4.49Bearish
- ADX17.19Weak Trend
- IndicatorValueSignal
- RSI32.19Neutral
- CCI-108.04Oversold
- ROC 9-1.13Bearish
- ROC 14-3.32Bearish
- ROC 25-2.92Bearish
- Stoch K13.28Oversold
- Stoch D16.54Oversold
- IndicatorValueSignal
- BB Upper635.30Neutral
- BB Middle620.17Neutral
- BB Lower605.05Neutral
- ATR5.39Low Volatility
- IndicatorValueSignal
- MFI30.68Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10617.26Bearish
- SMA 20623.10Bearish
- SMA 50630.19Bearish
- EMA 10616.74Bearish
- EMA 20621.35Bearish
- EMA 50627.96Bearish
- DEMA 10611.36Bearish
- DEMA 20614.49Bearish
- DEMA 50622.82Bearish
- TEMA 10609.93Bullish
- TEMA 20611.93Bearish
- TEMA 50614.57Bearish
- MACD-5.43Bearish
- ADX12.72Weak Trend
- IndicatorValueSignal
- RSI33.80Neutral
- CCI-136.45Oversold
- ROC 9-2.40Bearish
- ROC 14-2.76Bearish
- ROC 25-3.21Bearish
- Stoch K11.75Oversold
- Stoch D11.14Oversold
- IndicatorValueSignal
- BB Upper638.11Neutral
- BB Middle623.09Neutral
- BB Lower608.08Neutral
- ATR7.60Low Volatility
- IndicatorValueSignal
- MFI22.83Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10622.93Bearish
- SMA 20628.13Bearish
- SMA 50637.96Bearish
- EMA 10621.29Bearish
- EMA 20626.46Bearish
- EMA 50626.74Bearish
- DEMA 10614.82Bearish
- DEMA 20619.72Bearish
- DEMA 50638.79Bearish
- TEMA 10612.46Bearish
- TEMA 20614.39Bearish
- TEMA 50N/AN/A
- MACD-5.46Bearish
- ADX11.42Weak Trend
- IndicatorValueSignal
- RSI35.20Neutral
- CCI-181.93Oversold
- ROC 9-2.64Bearish
- ROC 14-4.39Bearish
- ROC 25-3.16Bearish
- Stoch K9.94Oversold
- Stoch D11.06Oversold
- IndicatorValueSignal
- BB Upper644.82Neutral
- BB Middle628.13Neutral
- BB Lower611.44Oversold
- ATR12.05High Volatility
- IndicatorValueSignal
- MFI35.93Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10628.91Bearish
- SMA 20636.60Bearish
- SMA 50608.23Bullish
- SMA 100589.24Bullish
- SMA 200640.46Bearish
- EMA 10627.91Bearish
- EMA 20628.72Bearish
- EMA 50615.40Bearish
- EMA 100611.47Bullish
- EMA 200609.07Bullish
- DEMA 10622.90Bearish
- DEMA 20634.23Bearish
- DEMA 50630.66Bearish
- DEMA 100608.35Bullish
- DEMA 200629.63Bearish
- TEMA 10618.50Bearish
- TEMA 20625.10Bearish
- TEMA 50648.06Bearish
- TEMA 100612.05Bullish
- TEMA 200601.58Bullish
- MACD2.51Bearish
- ADX13.56Weak Trend
- IndicatorValueSignal
- RSI44.06Neutral
- CCI-177.06Oversold
- ROC 14-3.53Bearish
- ROC 251.06Bullish
- Stoch K10.22Oversold
- Stoch D13.05Oversold
- IndicatorValueSignal
- BB Upper660.19Neutral
- BB Middle636.60Neutral
- BB Lower613.01Neutral
- ATR18.98Low Volatility
- IndicatorValueSignal
- MFI26.85Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20582.90Bullish
- SMA 50632.27Bearish
- EMA 20607.81Bullish
- EMA 50601.73Bullish
- DEMA 20605.53Bullish
- DEMA 50634.74Bearish
- TEMA 20613.50Bullish
- TEMA 50607.46Bullish
- MACD1.92Bullish
- ADX26.70Strong Trend
- IndicatorValueSignal
- RSI53.96Neutral
- CCI3.77Neutral
- ROC 1413.54Bullish
- ROC 25-10.22Bearish
- Stoch K80.47Overbought
- Stoch D84.44Overbought
- IndicatorValueSignal
- BB Upper657.28Neutral
- BB Middle582.90Neutral
- BB Lower508.51Neutral
- ATR41.38Low Volatility
- IndicatorValueSignal
- MFI53.94Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6592.25Bullish
- SMA 12624.69Bullish
- SMA 24545.96Bullish
- EMA 6602.19Bullish
- EMA 12595.18Bullish
- EMA 24547.49Bullish
- DEMA 6597.74Bullish
- DEMA 12627.47Bullish
- DEMA 24644.55Bearish
- TEMA 6591.79Bullish
- TEMA 12603.22Bullish
- TEMA 24651.99Bearish
- MACD102.55Bearish
- ADX52.96Strong Trend
- IndicatorValueSignal
- RSI62.20Neutral
- CCI109.67Overbought
- ROC 2575.16Bullish
- ROC 50137.57Bullish
- Stoch K71.55Neutral
- Stoch D81.21Overbought
- IndicatorValueSignal
- BB Upper735.37Neutral
- BB Middle578.65Neutral
- BB Lower421.93Neutral
- ATR76.98High Volatility
- IndicatorValueSignal
- MFI74.09Neutral